Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Anal Chem. 2022 Oct 20;94(43):14925–14930. doi: 10.1021/acs.analchem.2c02389

Figure 4.

Figure 4.

ARFRP1 modulates radioresistance in breast cancer cells. (A) Western blot for validating the knockdown efficiency of ARFRP1 in MDA-MB-231 cells. (B) Survival rates of MDA-MB-231 cells treated with control or ARFRP1 shRNA and exposed with the indicated doses of X-rays. Error bars represent S.D. (n = 3). The p values were calculated using two-tailed, unpaired Student’s t-test: *, p < 0.05; ***, p < 0.001. (C,D) Scatter plots showing the correlation of mRNA expression level of ARFRP1 gene to those of RALB (C) and RAC1 (D) genes in different breast cancer cell lines.